Evaluation of a computer-based adverse-drug-event monitor

American Journal of Health-System Pharmacy

Volumn 65, Issue 23, 2008, Pages 2265-2272

  Hwang, Soo Hee ^a   Lee, Sukhyang ^b   Koo, Hyun Kyung ^a   Kim, Yoon ^c,d  

^a Center for Interoperable Electronic Health Record   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Center for Interoperable Electronic Health Record

Author keywords

Computers; Errors, medication; Hospitals; Quality assurance

Indexed keywords

ADENOSINE; ADRENALIN; AMIKACIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIARRHEAL AGENT; ANTIDOTE; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ATROPINE; CARDIOVASCULAR AGENT; CORTICOSTEROID; FLUMAZENIL; GENTAMICIN; GLUCOSE; HALOPERIDOL; HEPARIN; HYDROCORTISONE; NALOXONE; NARCOTIC AGENT; PHENYTOIN; POLYSTYRENESULFONIC ACID; PROTAMINE SULFATE; TUBERCULOSTATIC AGENT; VANCOMYCIN; WARFARIN;

ADVERSE DRUG REACTION; ARTICLE; COMPUTER; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FEBRILE NEUTROPENIA; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICATION ERROR; MONITOR; PHARMACIST; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTH KOREA; TEACHING HOSPITAL; UNSPECIFIED SIDE EFFECT;

EID: 57149112581     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080122     Document Type: Article

References (38)

1. Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health-Syst Pharm. 2004; 61:1466-72.
2. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991; 324:377-84.
3. Thomas EJ, Studdert DM, Burstin HR et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000; 38:261-71.
4. Thomsen LA, Winterstein AG, Sondergaard B et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007; 41:1411-26.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200-5.
6. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA. 1997; 277:307-11.
7. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301-6.
8. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000; 12:69-76.
9. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003; 12:194-200.
10. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993; 8:289-94.
11. Jha AK, Kuperman GJ, Teich JM et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998; 5:305-14.
12. Hope C, Overhage JM, Seger A et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform. 2003; 36:92-8.
13. Kilbrige P, Classen DC. Surveillance for adverse drug events; history, methods, and current issues, 3rd ed. VHA research series. Irving, TX: VHA Inc.; 2002.
14. Murff HJ, Forster AJ, Peterson JF et al. Electronically screening discharge summaries for adverse medical events. J Am Med Inform Assoc. 2003; 10:339-50.
15. Dormann H, Criegee-Rieck M, Neubert A et al. Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gas troenterology. Aliment Pharmacol Ther. 2004; 19:303-9.
16. Morimoto T, Gandhi TK, Seger AC et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004; 13:306-14.
17. Levy M, Azaz-Livshits T, Sadan B et al. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharm. 1999; 54:887-92.
18. Dormann H, Muth-Selbach U, Krebs S et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf. 2000; 22:161-8.
19. Osheroff J, Teich J, Middleton B et al. A roadmap for national action on clinical decision support. J Am Med Inform Assoc. 2007; 14:141-5.
20. Chaudhry B, Wang J, Wu S et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Int Med. 2006; 144:742-52.
21. Holdsworth MT, Fichtl RE, Behta M et al. Incidence and impact of adverse drug events in pediatric inpatients. Arch Pediatr Adolesc Med. 2003; 157:60-5.
22. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study group. JAMA. 1995; 274:29-34.
23. American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am Health-Syst Pharm. 1998; 55:165-6.
24. Nebeker JR, Hurdle JF, Hoffman J. Developing a taxonomy for research in adverse drug events: potholes and signposts. Proc AMIA Symp. 2001:493-7.
25. Classen DC, Pestotnik SL, Evans RS et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266:2847-51.
26. Honigman B, Light P, Pulling RM et al. A computerized method for identifying incidents associated with adverse drug events in outpatients. Int J Med Inform. 2001; 61:21-32.
27. Monitoring adverse drug events: finding the needle in haystack. Vol. 9. VHA research series. Irving, TX: VHA Inc.; 2002.
28. Raschke RA, Gollihare B, Wunderlich TA et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA. 1998; 280:1317-20. [Erratum, JAMA. 1999; 281:4201
29. Thomson Reuters. MICROMEDEX Healthcare Series. www.thomsonhc.com/home/ dispatch (accessed 2008 Sep 24).
30. Dukes M. Meyler's side effects of drugs. 14th ed. Amsterdam: Elsevier; 2002.
31. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
32. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27:538. Letter.
33. Rawlins MD. Clinical pharmacology. Adverse reactions to drugs. Br Med J. (Clin Res Ed). 1981; 282:974-6.
34. Pere JC, Begaud B, Haramburu F et al. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther. 1986; 40:451-61.
35. Azaz-Livshits T, Levy M, Sadan B et al. Computerized surveillance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol. 1998; 45:309-14.
36. Handler SM, Altman RL, Perera S et al. A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. J Am Med Inform Assoc. 2007; 14:451-8. [Erratum, J Am Med Inform Assoc. 2007; 14:6861
37. World Health Organization. International statistical classification of diseases and related health problems, 10th revision. www.who.int/ classifications/apps/icd/icd10online/ (accessed 2008 Aug 19).
38. Institute for Research and Information in Health Economics. OECD health data 2008. www.ecosante.org/oecd.htm (accessed 2008 Aug 19).